Evidence map›Paper›PMID 39894946›Full record

ArticleJournal of the American Chemical Society2025

Semisynthesis of Isomerized Histone H4 Reveals Robustness and Vulnerability of Chromatin toward Molecular Aging.

Tianze Zhang, Luis F Guerra, Yana Berlina, Jon R Wilson, Beat Fierz, Manuel M Müller

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Mapping Allosteric Communication in the Nucleosome with Conditional Activity.Journal of chemical information and modeling · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tianze ZhangDepartment of Chemistry, King's College London, Britannia House, 7 Trinity Street, London SE1 1DB, U.K.
Luis F GuerraDepartment of Chemistry, King's College London, Britannia House, 7 Trinity Street, London SE1 1DB, U.K.ORCID 0000-0002-8960-1720
Yana BerlinaÉcole Polytechnique Fédérale de Lausanne (EPFL), ISIC, Lausanne CH-1015, Switzerland.
Jon R WilsonThe Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K.ORCID 0000-0002-5157-5432
Beat FierzÉcole Polytechnique Fédérale de Lausanne (EPFL), ISIC, Lausanne CH-1015, Switzerland.ORCID 0000-0002-2991-3044
Manuel M MüllerDepartment of Chemistry, King's College London, Britannia House, 7 Trinity Street, London SE1 1DB, U.K.ORCID 0000-0001-6701-0893

Funding

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
NIGMS NIH HHS R01 GM129325Wellcome Trust
6 · The paper itself

Abstract

Proteins are subject to aging in the form of spontaneous, nonenzymatic post-translational modifications (PTMs). One such PTM is the formation of the β-linked isomer l-isoaspartic acid (isoAsp) from aspartic acid (Asp) or asparagine residues, which tends to occur in long-lived proteins. Histones can exhibit half-lives on the order of 100 days, and unsurprisingly, isoAsp formation has been observed in nearly every histone family. Delineating the molecular consequences of isoAsp formation in histones is challenging due to the multitude of processes that occur on such time scales. To isolate the effects of a specific isoAsp modification thus necessitates precise

Indexed as

AsparagineAspartic AcidChromatinHistonesIsoaspartic AcidIsomerismMagnesiumMethylationOrganic Chemistry PhenomenaProtein Processing, Post-TranslationalAsparagineAspartic AcidChromatinHistonesIsoaspartic AcidMagnesium

Identifiers

PMID39894946
PMCPMC11826994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.